Likely active: portfolio news Sep 2025 Verified 5 Nov 2026
Apple Tree Venture
New York, NY life sciences venture firm that creates and funds biotechnology companies from early science or spinouts, investing from seed stage through IPO.
- Type
- VC firm
- Location
- New York, New York, United States
- Stages
- Pre-seed, Seed, Series A, Series B, Growth
- Backs
- Biotech and pharma
- Sectors
- Biotech, Healthtech and life sciences
- Fund size / AUM
- $3.55B gross private fund assets (Form ADV; private funds: 1, of which venture capital: 1)
- Portfolio mix
- Biotech and pharma 87%; Climate and energy 6%; Medtech and digital health 6%; B2B software 2% (n=28, 2001 to 2026)
- UK office
- London
- Website
- www.appletreepartners.com
Contacts on file
For Apple Tree Venture, the paid file holds: 8 named decision-makers with roles; firm contact email (domain checked).
Get US Complete, $197 Free sample
One-time payment. No subscription. No account.
Notable investments
Akero TherapeuticsChinook TherapeuticsMarengo TherapeuticsAulos BioscienceHeartWare International
Sources
- adviserinfo.sec.gov/firm/summary/163705
- www.appletreepartners.com/
- www.appletreepartners.com/portfolio
- www.appletreepartners.com/contact
- www.appletreepartners.com/team
Last checked 5 Nov 2026. Is something wrong? Tell us.
Appears in 44 lists
Series B investors in New York (29)Biotech investors in New York (29)Series B biotech investors in the US (34)Growth-stage biotech investors in the US (44)Series A investors in New York (49)Growth-stage investors in New York (57)Series A biotech investors in the US (59)International investors with a UK office (67)Series B healthtech investors in the US (69)Series B biotech investors (73)Pre-seed biotech investors in the US (81)Pre-seed investors in New York (82)Healthtech investors in New York (100)Growth-stage biotech investors (109)Growth-stage healthtech investors in the US (121)Seed investors in New York (128)Pre-seed biotech investors (148)Series A biotech investors (153)Seed biotech investors in the US (159)Series B healthtech investors (160)Series A healthtech investors in the US (164)Series B investors in the US (165)Pre-seed healthtech investors in the US (225)Growth-stage investors in the US (288)Biotech venture capital firms in the US (297)Seed biotech investors (300)Growth-stage healthtech investors (316)Series B investors (339)Series A investors in the US (372)Series A healthtech investors (401)Pre-seed healthtech investors (408)Seed healthtech investors in the US (437)Venture capital firms in New York (440)Biotech investors (484)Pre-seed investors in the US (549)Growth-stage investors (705)Healthtech venture capital firms in the US (709)Seed healthtech investors (800)Series A investors (864)Pre-seed investors (988)Seed investors in the US (1,043)Healthtech investors (1,207)Seed investors (1,892)Venture capital firms in the US (2,975)